Robert Lorne Abel, the See Remarks of $SDGR, sold 1,230 shares of the company on 02-09-2026 for an estimated $16,617. We received data on the trade from a recent SEC filing. This was a sale of approximately 6.0% of their shares of this class of stock. Following this trade, they now own 19,385 shares of this class of $SDGR stock.
$SDGR Insider Trading Activity
$SDGR insiders have traded $SDGR stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $SDGR stock by insiders over the last 6 months:
- MARGARET DUGAN (Chief Medical Officer) sold 1,395 shares for an estimated $29,387
- ROBERT LORNE ABEL (See Remarks) sold 1,230 shares for an estimated $16,617
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$SDGR Hedge Fund Activity
We have seen 100 institutional investors add shares of $SDGR stock to their portfolio, and 128 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 3,192,038 shares (+93.5%) to their portfolio in Q3 2025, for an estimated $64,032,282
- CADIAN CAPITAL MANAGEMENT, LP removed 3,045,952 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $61,101,797
- MILLENNIUM MANAGEMENT LLC added 1,419,750 shares (+1075.8%) to their portfolio in Q3 2025, for an estimated $28,480,185
- LAZARD ASSET MANAGEMENT LLC added 927,234 shares (+65.3%) to their portfolio in Q3 2025, for an estimated $18,600,314
- FARALLON CAPITAL MANAGEMENT LLC removed 822,000 shares (-74.3%) from their portfolio in Q3 2025, for an estimated $16,489,319
- MORGAN STANLEY added 585,126 shares (+50.8%) to their portfolio in Q3 2025, for an estimated $11,737,627
- UBS GROUP AG added 489,059 shares (+51.3%) to their portfolio in Q4 2025, for an estimated $8,744,374
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$SDGR Revenue
$SDGR had revenues of $54.3M in Q3 2025. This is an increase of 53.94% from the same period in the prior year.
You can track SDGR financials on Quiver Quantitative's SDGR stock page.
$SDGR Analyst Ratings
Wall Street analysts have issued reports on $SDGR in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- TD Cowen issued a "Buy" rating on 01/08/2026
- B of A Securities issued a "Buy" rating on 12/15/2025
- Keybanc issued a "Overweight" rating on 10/08/2025
To track analyst ratings and price targets for $SDGR, check out Quiver Quantitative's $SDGR forecast page.
$SDGR Price Targets
Multiple analysts have issued price targets for $SDGR recently. We have seen 6 analysts offer price targets for $SDGR in the last 6 months, with a median target of $21.5.
Here are some recent targets:
- Scott Schoenhaus from Keybanc set a target price of $25.0 on 01/08/2026
- Brendan Smith from TD Cowen set a target price of $24.0 on 01/08/2026
- Michael Yee from UBS set a target price of $18.0 on 01/07/2026
- Michael Ryskin from B of A Securities set a target price of $24.0 on 12/15/2025
- Andrea Newkirk from Goldman Sachs set a target price of $19.0 on 09/30/2025
- Vikram Malhorta from Morgan Stanley set a target price of $19.0 on 08/18/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
